Looking to invest in AI stocks? Read this article to learn why Recursion Pharma and C3.ai may not be the best choices due to failing investor expectations. Find alternative options with better prospects.
European businesses in China face uncertainty due to ambiguous and unpredictable Chinese laws. Lack of clear definitions and complex procedures add to the challenges. How will these regulations impact operations?
Concerns rise over AI's impact on jobs & livelihoods. Generative AI may replace 300 million jobs. Anxiety grows among professionals & employers. A delicate balance between innovation & regulation needed.